Novel Compound Characterization Testing
Understand your targeted therapeutic and prepare your nonstandard program as it advances through discovery and development with product characterization testing. Novel molecules, such as antibody-drug conjugates (ADCs), polymer-drug conjugates, and other combinations, represent a growing market segment. Our team applies our significant experience and capabilities in developing small molecules, biologics, and other novel constructs for your product optimization.
Whatever your complex molecule consists of (e.g., proteins, nucleic acids, small molecules, or combinations), we use a variety of analytical methods to reveal the relevant properties that inform drug development. For example, ADCs may be highly heterogenous because the cytotoxic payload is attached to the protein monoclonal antibody (mAb) via a covalent linkage. the resulting conjugate may be highly heterogeneous. This inherent heterogeneity significantly impacts the complexity of discovery and development pathways, requiring a tailored approach. Our team utilizes existing methods and develops new orthogonal methods to ensure proper drug substance and drug product development that fits your molecule’s unique needs.
Integrated Laboratory Services
When your team needs additional CDMO support, our scientists are ready. Our state-of-the-art facilities and highly trained experts add power to your project.